A genetically modified beneficial strain of bacteria blocks intestinal inflammation in a preclinical model of inflammatory bowel disease and has the potential to treat intestinal-based diseases
Departments, Centers, & Programs:
Mass General Infectious Diseases
55 Fruit St.
Boston, MA 02114
- MD, UC San Francisco School of Medicine
- Residency, University of Washington Hospitals
American Board Certifications
- Infectious Disease, American Board of Internal Medicine
Accepted Insurance Plans
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.